-
公开(公告)号:US20250066750A1
公开(公告)日:2025-02-27
申请号:US18795872
申请日:2024-08-06
Applicant: Massachusetts Institute of Technology
Inventor: Joseph M. Jacobson , Noah Michael Jakimo , Pranam Chatterjee
Abstract: A Streptococcus canis Cas9 (ScCas9) ortholog and its engineered variants, possessing novel PAM specificity, is an addition to the family of CRISPR-Cas9 systems. ScCas9 endonuclease is used in complex with guide RNA, consisting of identical non-target-specific sequence to that of the guide RNA SpCas9, for specific recognition and activity on a DNA target immediately upstream of either an “NNGT” or “NNNGT” PAM sequence. A novel DNA-interacting loop domain within ScCas9, and other Cas9 orthologs, such as those from Streptococcus gordonii and Streptococcus angionosis facilitates a divergent PAM sequence from the “NGG” PAM of SpCas9.
-
公开(公告)号:US12188098B2
公开(公告)日:2025-01-07
申请号:US18463079
申请日:2023-09-07
Applicant: TORAY INDUSTRIES, INC. , NATIONAL CANCER CENTER
Inventor: Junpei Kawauchi , Hitoshi Nobumasa , Satoko Kozono , Satoshi Kondou , Hiroko Sudo , Atsushi Ochiai , Motohiro Kojima
IPC: C07H21/02 , C12M1/00 , C12M1/34 , C12N15/09 , C12Q1/6886 , G01N33/53 , G01N33/574 , G01N37/00
Abstract: This invention provides a kit or a device for the detection of pancreatic cancer, comprising a nucleic acid(s) capable of specifically binding to a miRNA(s) in a sample from a subject, and a method for detecting pancreatic cancer, comprising measuring the miRNA(s) in vitro.
-
公开(公告)号:US12186756B2
公开(公告)日:2025-01-07
申请号:US17243770
申请日:2021-04-29
Applicant: Go!Foton, Inc.
Inventor: Takashi Fukuzawa
Abstract: A reaction processor includes: a vessel installation unit for installing a reaction processing vessel provided with a channel formed in a substrate; a high temperature heater and a medium temperature heater for adjusting the temperature of the channel of the reaction processing vessel; a vessel alignment mechanism for adjusting the position of the reaction processing vessel 10; and a housing that has a housing main unit and a cover portion capable of being opened and closed with respect to the housing main unit and that houses the vessel installation unit, the high temperature heater, the medium temperature heater, and the vessel alignment mechanism. In conjunction with the state of the cover portion being changed from an open state to a closed state, the vessel alignment mechanism aligns the reaction processing vessel such that the reaction processing vessel can be heated by the high temperature heater and the medium temperature heater.
-
公开(公告)号:US12173330B2
公开(公告)日:2024-12-24
申请号:US18157226
申请日:2023-01-20
Applicant: API CORPORATION
Inventor: Ryoma Miyake , Hiroshi Kawabata
Abstract: A method of producing high-purity hydroxy-L-pipecolic acids that includes allowing an L-pipecolic acid hydroxylase, a microorganism or cell having the ability to produce the enzyme, a processed product of the microorganism or cell, and/or a culture liquid comprising the enzyme and obtained by culturing the microorganism or cell, to act on L-pipecolic acid as a substrate in the presence of 2-oxoglutaric acid and ferrous ion, wherein the L-pipecolic acid hydroxylase (1) acts on L-pipecolic acid in the presence of 2-oxoglutaric acid and ferrous ion to add a hydroxy group to the carbon atom at positions 3, 4, and/or 5 of L-pipecolic acid; and (2) has a catalytic efficiency (kcat/Km) with L-proline that is equal to or less than 7 times the catalytic efficiency (kcat/Km) with L-pipecolic acid.
-
公开(公告)号:US20240417722A1
公开(公告)日:2024-12-19
申请号:US18534209
申请日:2023-12-08
Applicant: NOVARTIS AG , INTELLIA THERAPEUTICS, INC.
Inventor: Ming-Wei CHEN , Melissa DECK , Glenn DRANOFF , Craig Stephen MICKANIN , Reynald LESCARBEAU , Celeste RICHARDSON , Morag STEWART , Yi YANG
IPC: C12N15/113 , A61K9/00 , A61K31/7088 , A61K38/17 , A61K38/46 , A61K39/00 , A61K45/06 , C12N5/0783 , C12N15/09 , C12N15/10
Abstract: The present invention is directed to genome editing systems, reagents and methods for immunooncology.
-
公开(公告)号:US20240384234A1
公开(公告)日:2024-11-21
申请号:US18787081
申请日:2024-07-29
Applicant: KEIO UNIVERSITY
Inventor: Minoru KO
IPC: C12N5/077 , C12N5/071 , C12N5/0793 , C12N15/09 , C12N15/113
Abstract: In related-art methods of differentiating pluripotent stem cells into a desired cell type, there has not been established a differentiation induction method using human ES/iPS cells and being highly efficient. Many attempts have been made, including a stepwise differentiation induction method based on the control of culture conditions or the addition of, for example, various cell growth factors/differentiation factors to a culture solution, but the use of complicated culture steps is a big problem. A method of inducing differentiation into a desired cell type within a short period of time and with high efficiency by use of a pluripotent stem cell that actively undergoes cell differentiation, which is obtained by reducing an undifferentiated state of the pluripotent stem cell, has been developed, and thus the present invention has been completed.
-
公开(公告)号:US12103967B2
公开(公告)日:2024-10-01
申请号:US18509252
申请日:2023-11-14
Applicant: Hoffmann-La Roche Inc.
Inventor: Jens Fischer , Guy Georges , Anton Jochner , Gregor Jordan , Hubert Kettenberger , Joerg Moelleken , Tilman Schlothauer , Georg Tiefenthaler , Valeria Runza , Meher Majety , Martin Schaefer , Maria Viert , Shu Feng , Wei Shiong Adrian Ho , Siok Wan Gan , Runyi Adeline Lam , Michael Gertz
CPC classification number: C07K16/24 , A61K39/385 , A61K2039/505 , C07K16/46 , C07K2317/31 , C07K2317/565 , C12N5/06 , C12N15/09 , C12N15/63
Abstract: The present invention relates to bispecific anti-CCL2 antibodies binding to two different epitopes on human CCL2, pharmaceutical compositions thereof, their manufacture, and use as medicaments for the treatment of cancers, inflammatory, autoimmune and ophthalmologic diseases.
-
公开(公告)号:US12092645B2
公开(公告)日:2024-09-17
申请号:US18059404
申请日:2022-11-28
Applicant: SHIMADZU CORPORATION , MEIJO UNIVERSITY
Inventor: Hiroto Tamura , Naomi Yamamoto , Teruyo Kato , Keisuke Shima , Shinji Funatsu
CPC classification number: G01N33/6848 , C12Q1/04 , C12N15/09 , G01N2333/195 , G01N2560/00
Abstract: To provide a method for discriminating a microorganism by selecting and using a marker protein capable of reproducibly and quickly discriminating a bacterial species of the genus Listeria. The method for discriminating a microorganism according to the present invention includes: a step of subjecting a sample containing a microorganism to mass spectrometry to obtain a mass spectrum; a reading step of reading a mass-to-charge ratio m/z of a peak derived from a marker protein from the mass spectrum; and a discrimination step of discriminating which bacterial species of Listeria bacteria the microorganism contained in the sample contains based on the mass-to-charge ratio m/z, in which at least one of 17 ribosomal proteins L3, L4, L23, L2, L24, L6, L18, S5, L15, S13, S11, L10, L21, L13, S9, L31, S16 is used as the marker protein and particularly at least one of 8 ribosomal proteins L24, L6, L18, L15, S9, L31, S16 among the 17 ribosomal proteins is used.
-
公开(公告)号:US20240294966A1
公开(公告)日:2024-09-05
申请号:US18416592
申请日:2024-01-18
Applicant: KAO Corporation
Inventor: Takayoshi INOUE , Akira HACHIYA
IPC: C12Q1/6806 , B32B5/18 , C12N15/09 , C12Q1/68 , C12Q1/686 , C12Q1/6883 , C12Q1/6886
CPC classification number: C12Q1/6806 , B32B5/18 , C12N15/09 , C12Q1/68 , C12Q1/686 , C12Q1/6883 , C12Q1/6886 , C12Q2600/112 , C12Q2600/118 , C12Q2600/158 , C12Q2600/16 , C12Q2600/166 , C12Q2600/178
Abstract: Provided is a method by which a nucleic acid sample can be collected from a subject minimally invasively. A method for preparing a nucleic acid derived from a skin cell of a subject, comprising isolating the nucleic acid from skin surface lipids collected from the subject.
-
公开(公告)号:US12037577B2
公开(公告)日:2024-07-16
申请号:US17653441
申请日:2022-03-03
Applicant: Roche Sequencing Solutions, Inc.
Inventor: Mark Stamatios Kokoris , Marc Prindle , Melud Nabavi , Craig Ostrander , Taylor Lehmann , Samantha Vellucci , Michael Kovarik , Jack Chase , Robert Busam , Miranda Lahman
CPC classification number: C12N15/10 , C07H21/04 , C12N9/1252 , C12Y207/07007
Abstract: Recombinant DPO4-type DNA polymerase variants with amino acid substitutions that confer modified properties upon the polymerase for improved single molecule sequencing applications are provided. Such properties may include enhanced binding and incorporation of bulky nucleotide analog substrates into daughter strands and the like. Also provided are compositions comprising such DPO4 variants and nucleotide analogs, as well as nucleic acids which encode the polymerases with the aforementioned phenotypes.
-
-
-
-
-
-
-
-
-